Morgan Stanley Bio Xcel Therapeutics, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 40,614 shares of BTAI stock, worth $20,713. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,614

Previous 116,563 65.16%

Holding current value

$20,713

Previous $149,000 83.89%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.53 - $1.34 $40,252 - $101,771	-75,949 Reduced 65.16%	40,614 $24,000
Q2 2024 Oct 17, 2024	SELL	$1.14 - $2.97 $120,539 - $314,035	-105,736 Reduced 47.56%	116,563 $149,000
Q2 2024 Aug 14, 2024	SELL	$1.14 - $2.97 $120,539 - $314,035	-105,736 Reduced 47.56%	116,563 $149,000
Q1 2024 Oct 17, 2024	BUY	$1.95 - $4.04 $206,185 - $427,173	105,736 Added 90.71%	222,299 $626,000
Q1 2024 Aug 16, 2024	BUY	$1.95 - $4.04 $59,562 - $123,401	30,545 Added 15.93%	222,299 $626,000
Q1 2024 May 15, 2024	BUY	$1.95 - $4.04 $59,562 - $123,401	30,545 Added 15.93%	222,299 $626,000
Q4 2023 Aug 16, 2024	BUY	$2.32 - $5.51 $174,443 - $414,302	75,191 Added 64.51%	191,754 $565,000
Q4 2023 Feb 13, 2024	SELL	$2.32 - $5.51 $26,728 - $63,480	-11,521 Reduced 5.67%	191,754 $565,000
Q3 2023 Nov 15, 2023	BUY	$2.49 - $11.85 $274,915 - $1.31 Million	110,408 Added 118.89%	203,275 $514,000
Q2 2023 Aug 14, 2023	SELL	$6.39 - $28.58 $237,848 - $1.06 Million	-37,222 Reduced 28.61%	92,867 $618,000
Q1 2023 May 15, 2023	BUY	$17.7 - $33.24 $90,128 - $169,258	5,092 Added 4.07%	130,089 $2.43 Million
Q4 2022 Feb 14, 2023	SELL	$10.25 - $22.43 $1.33 Million - $2.91 Million	-129,745 Reduced 50.93%	124,997 $2.68 Million
Q3 2022 Nov 14, 2022	BUY	$11.19 - $17.89 $312,201 - $499,131	27,900 Added 12.3%	254,742 $3.01 Million
Q2 2022 Oct 27, 2022	BUY	$9.03 - $21.55 $142,908 - $341,050	15,826 Added 7.5%	226,842 $2.99 Million
Q2 2022 Aug 15, 2022	BUY	$9.03 - $21.55 $142,908 - $341,050	15,826 Added 7.5%	226,842 $2.99 Million
Q1 2022 Oct 27, 2022	SELL	$15.0 - $22.83 $237,390 - $361,307	-15,826 Reduced 6.98%	211,016 $4.41 Million
Q1 2022 May 13, 2022	SELL	$15.0 - $22.83 $355,665 - $541,322	-23,711 Reduced 10.1%	211,016 $4.41 Million
Q4 2021 Feb 14, 2022	BUY	$20.12 - $35.09 $2.29 Million - $4 Million	113,987 Added 94.41%	234,727 $4.77 Million
Q3 2021 Nov 15, 2021	BUY	$23.84 - $32.03 $2.88 Million - $3.87 Million	120,740 New	120,740 $3.66 Million

Others Institutions Holding BTAI

# of Institutions

Shares Held

3.14M

Call Options Held

22.2K

Put Options Held

40.2K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $14.3M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account